PEAK PHARMACEUTICALS, INC. - FORM 10-Q - EX-32.2 - SECTION 906 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL - May 14, 2018

Attached files

file filename
EX-10.4 - CONVERTIBLE PROMISSORY NOTE DATED @@ @@, 2018 WITH SUKH ATHWAL - PEAK PHARMACEUTICALS, INC.ex_10-4.htm
EX-32.1 - SECTION 906 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL - PEAK PHARMACEUTICALS, INC.ex_32-1.htm
EX-31.2 - SECTION 302 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL - PEAK PHARMACEUTICALS, INC.ex_31-2.htm
EX-31.1 - SECTION 302 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL - PEAK PHARMACEUTICALS, INC.ex_31-1.htm
EX-10.6 - FIRST AMENDMENT TO CONVERTIBLE PROMISSORY NOTE DATED MAY 7, 2018 WITH TRIUS HOLD - PEAK PHARMACEUTICALS, INC.ex_10-6.htm
EX-10.5 - FIRST AMENDMENT TO CONVERTIBLE PROMISSORY NOTE DATED MAY 7, 2018 WITH SUKH ATHWA - PEAK PHARMACEUTICALS, INC.ex_10-5.htm
EX-10.3 - CONVERTIBLE PROMISSORY NOTE DATED JANUARY 10, 2018 WITH MEDIAPARK INVESTMENTS LI - PEAK PHARMACEUTICALS, INC.ex_10-3.htm
10-Q - PEAK PHARMACEUTICALS, INC. 10-Q - PEAK PHARMACEUTICALS, INC.peakpharmaceuticals_10q.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned, Neil Reithinger, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(a)The quarterly report on Form 10-Q of Peak Pharmaceuticals, Inc. for the quarter ended March 31, 2018 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(b)Information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: May 14, 2018
   
By: /s/ Neil Reithinger
Name: Neil Reithinger
Title: Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

 

 

PEAK PHARMACEUTICALS, INC. Reports